Football
Juventus to wait on Barca’s Alba
Juventus want to sign Barcelona full-back Jordi Alba and are willing to wait until 2020 to sign him on a free transfer.
The Old Lady are said to have already had extensive contact with the defender’s representative Vicente Forés, and have tried to convince him that Juve are the ideal club to maximise the remainder of his career.
Alba’s contract at the Camp Nou has entered its final 18 months, despite the Spaniard being Barca’s first-choice left-back and in fine form.
The Bianconeri are said to be deploying a similar tactic that saw them land Emre Can from Liverpool on a free transfer and which they are currently working on with Arsenal’s Aaron Ramsey.
In November, El Mundo Deportivo said an offer of extension until 2023 will be offered and despite the 29-year-old willing to commit his future to the club, the economic demands are reportedly not being met.
Manchester United are also reported to hold an interest in the Spain international, fuelled by the defender’s apparent unhappiness at not being offered a new deal earlier.
The left-back’s current deal at the Camp Nou expires in June 2020 and possesses a €150m release clause but he wants an improved contract.
Alba has played more than 250 matches for Barca after his 2012 move from Valencia with his last renewal penned in 2015.
-
Features7 days agoHow ADC leadership crisis put Atiku’s 2027 ambition at risk
-
Energy7 days agoNNPC plans 5–10% stock market listing, targets 2027 for IPO preparations
-
Business7 days agoLoveWorld Expo 2026 to showcase global innovations, emerging technologies in Lagos
-
Business4 days agoDisCos urge Minister to end blame game, apologise to Nigerians over blackouts
-
Latest7 days ago2027: No Court rulings can keep me off the ballot, Atiku insists
-
Latest1 week ago2027: Wike declares Obi’s political wave dead, dismisses chances of presidential victory
-
Latest1 week agoNDC faults Tinubu’s $7.7bn external loan request, raises debt concerns
-
Health5 days agoStudy links Pfizer COVID-19 vaccine to higher death rates than Moderna shot


